Contents
Recent Patents on Cardiovascular Drug Discovery (Discontinued), Volume 1 - Number 2
Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase
, 1(2): 129 - 139Nangaku Nangaku, Ichiro Kojima, Tetsuhiro Tanaka, Takamoto Ohse, Hideki Kato and Fujita Fujita
DOI: 10.2174/157489006777442522
99mTc-N-DBODC5: A Novel Myocardial Perfusion Imaging Agent for Diagnosis of Coronary Artery Disease, a Review
, 1(2): 161 - 166Tohoru Takeda, Jin Wu and Thet-Thet-Lwin
DOI: 10.2174/157489006777442496
Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications
, 1(2): 167 - 175Zia A. Khan and Subrata Chakrabarti
DOI: 10.2174/157489006777442531
Vasopressin Receptor Antagonists in Heart Failure
, 1(2): 177 - 184Robert E. Hobbs and W. H. Wilson Tang
DOI: 10.2174/157489006777442513
Levosimendan: A Novel Agent in Heart Failure
, 1(2): 185 - 191Nikolas Koumallos, Charalambos Antoniades, Dimitris Tousoulis, Cheerag Shirodaria and Christodoulos Stefanadis
DOI: 10.2174/157489006777442487
Role of PPAR in Cardiovascular Diseases
, 1(2): 193 - 209Saibal K. Das and Ranjan Chakrabarti
DOI: 10.2174/157489006777442441
Fibroblast Growth Factors, Fibroblast Growth Factor Receptors, Diseases, and Drugs
, 1(2): 211 - 224Gregory J. Chen and Reza Forough
DOI: 10.2174/157489006777442478
Webmaster Contact: info@benthamscience.org